Addus HomeCare Co. (NASDAQ:ADUS) Short Interest Update

Addus HomeCare Co. (NASDAQ:ADUS) was the target of a significant increase in short interest during the month of December. As of December 15th, there was short interest totalling 452,000 shares, an increase of 6.4% from the November 30th total of 425,000 shares. Based on an average daily volume of 135,600 shares, the short-interest ratio is currently 3.3 days.

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $125.35 on Thursday. Addus HomeCare has a one year low of $85.94 and a one year high of $136.12. The business’s 50-day moving average price is $125.29 and its two-hundred day moving average price is $125.71. The company has a market capitalization of $2.27 billion, a P/E ratio of 28.68, a price-to-earnings-growth ratio of 2.11 and a beta of 1.02.

Addus HomeCare (NASDAQ:ADUS) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, beating the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.03 EPS. On average, equities analysts anticipate that Addus HomeCare will post 4.59 EPS for the current year.

Insider Activity at Addus HomeCare

In other news, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction on Monday, December 9th. The stock was sold at an average price of $121.00, for a total transaction of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO R Dirk Allison sold 12,500 shares of the company’s stock in a transaction on Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Institutional Trading of Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. Texas Permanent School Fund Corp lifted its stake in shares of Addus HomeCare by 0.6% in the 2nd quarter. Texas Permanent School Fund Corp now owns 14,089 shares of the company’s stock valued at $1,636,000 after purchasing an additional 82 shares during the last quarter. Arizona State Retirement System raised its holdings in Addus HomeCare by 2.0% during the second quarter. Arizona State Retirement System now owns 4,543 shares of the company’s stock valued at $527,000 after buying an additional 87 shares in the last quarter. Inspire Investing LLC lifted its position in shares of Addus HomeCare by 3.3% in the third quarter. Inspire Investing LLC now owns 3,111 shares of the company’s stock worth $414,000 after buying an additional 100 shares during the last quarter. New York State Teachers Retirement System boosted its stake in shares of Addus HomeCare by 1.2% during the 3rd quarter. New York State Teachers Retirement System now owns 8,510 shares of the company’s stock worth $1,132,000 after acquiring an additional 100 shares in the last quarter. Finally, Equitable Trust Co. increased its holdings in shares of Addus HomeCare by 2.2% during the 3rd quarter. Equitable Trust Co. now owns 4,825 shares of the company’s stock valued at $642,000 after acquiring an additional 106 shares during the last quarter. 95.35% of the stock is owned by institutional investors.

Analysts Set New Price Targets

ADUS has been the subject of several research analyst reports. KeyCorp began coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target for the company. Stephens increased their target price on Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. Macquarie reiterated an “outperform” rating and set a $139.00 price target on shares of Addus HomeCare in a report on Monday, November 4th. StockNews.com raised Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday, December 11th. Finally, Royal Bank of Canada restated an “outperform” rating and set a $136.00 price objective on shares of Addus HomeCare in a research report on Thursday, November 14th. One equities research analyst has rated the stock with a sell rating, nine have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus target price of $133.67.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.